What is Remsleep Holding's earnings per share (EPS)?

Remsleep Holding (RMSL) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Remsleep Holding Financials

RMSL

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Remsleep Holding (RMSL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RMSL FY2025 2026-04-22

REMSleep’s business mechanic is external-funding dependence: tiny revenue does not support overhead, interest, or near-term liabilities.

Across the last three valid years, revenue contracted sharply while operating cash burn stayed near -$0.5M to -$0.8M, showing the cash drain comes from maintaining the organization rather than from serving a growing order base. In FY2025, $215K of cash sat against -$503K of operating cash flow, so the company was still being financed more by capital raising than by customer activity.

Interest expense of $388K was almost one hundred times FY2025 gross profit of $4K, so financing costs now matter more than product economics. That is why the gross-margin improvement to 24.0% says little about traction when total revenue was only $17K.

The balance sheet has shifted to equity-thin financing: debt-to-equity reached 9.6x in FY2025 as equity fell to $32K. With a sub-1.0x current ratio and liabilities close to assets, day-to-day liquidity now has much less cushion than it did a year earlier.

Financial Health Signals

Financial Profile 2/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Remsleep Holding's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Remsleep Holding's revenue declined 85.7% year-over-year, from $117K to $17K. This contraction results in a growth score of 0/100.

Leverage

Remsleep Holding has elevated debt relative to equity (D/E of 9.60), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Remsleep Holding's current ratio of 0.89 is below the typical benchmark, resulting in a score of 12/100. However, the company holds substantial cash reserves (72% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.

Piotroski F-Score Weak

1/9

Remsleep Holding passes 1 of 9 financial strength tests. No profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$17K

YoY-85.7%

Remsleep Holding generated $17K in revenue in fiscal year 2025. This represents a decrease of 85.7% from the prior year.

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$0.00

Remsleep Holding earned $0.00 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$215K

YoY-53.7%

5Y CAGR+13.4%

10Y CAGR+113.7%

Remsleep Holding held $215K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

1.62B

YoY+6.2%

Remsleep Holding had 1.62B shares outstanding in fiscal year 2025. This represents an increase of 6.2% from the prior year.

Margins & Returns

Gross Margin

24.0%

YoY+8.6pp

Remsleep Holding's gross margin was 24.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 8.6 percentage points from the prior year.

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

RMSL Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$17K-85.7%	$117K-42.5%	$204K-36.5%	$321K	N/A	N/A
Cost of Revenue	$13K-87.2%	$99K-89.7%	$960K+286.6%	$248K	N/A	N/A
Gross Profit	$4K-77.7%	$18K+102.4%	-$757K-1146.8%	$72K	N/A	N/A
R&D Expenses	N/A	$187K-36.4%	$295K-12.5%	$337K+160.6%	$129K+78.1%	$73K
SG&A Expenses	$383K+42.3%	$269K-8.8%	$295K-40.0%	$492K+277.7%	$130K-9.6%	$144K
Operating Income	N/A	-$794K+55.2%	-$1.8M-45.5%	-$1.2M-186.1%	-$426K+9.4%	-$470K
Interest Expense	$388K+171.1%	$143K+938.9%	$14K-94.2%	$237K-74.2%	$919K+50.2%	$612K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$1.1M+39.4%	-$1.8M-19.6%	-$1.5M+61.1%	-$3.8M	N/A
EPS (Diluted)	$0.00	$0.00	$0.00	$0.00+100.0%	$-0.01	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	N/A	$7K+54.5%	$5K	N/A	N/A	$37K+35.0%	$28K-52.3%	$58K
Cost of Revenue	N/A	$28-95.3%	$600	N/A	N/A	$59K+885.9%	$6K-56.3%	$14K
Gross Profit	N/A	$7K+75.8%	$4K	N/A	N/A	-$21K-198.4%	$22K-51.1%	$44K
R&D Expenses	N/A	N/A	$2K-91.3%	$17K	N/A	$41K-69.1%	$132K+495.0%	$22K
SG&A Expenses	N/A	$77K-6.0%	$82K+50.5%	$54K	N/A	$42K-49.7%	$84K-2.0%	$85K
Operating Income	N/A	-$2.3M-1622.5%	-$133K-0.9%	-$131K	N/A	-$194K+34.6%	-$297K-139.0%	-$124K
Interest Expense	N/A	$130K-9.4%	$144K+88.2%	$76K	N/A	$64K+95.5%	$33K+1190.9%	$3K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$2.3M-703.5%	-$288K-236.6%	-$85K	N/A	-$278K-23.2%	-$226K+10.7%	-$253K
EPS (Diluted)	N/A	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00

RMSL Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$340K-42.6%	$592K-51.0%	$1.2M-64.1%	$3.4M-3.9%	$3.5M+1416.8%	$231K
Current Assets	$265K-46.1%	$492K-41.2%	$836K-71.3%	$2.9M-14.0%	$3.4M+2600.6%	$125K
Cash & Equivalents	$215K-53.7%	$463K-35.6%	$719K-61.0%	$1.8M-45.6%	$3.4M+2862.1%	$114K
Inventory	$46K+411.6%	$9K-90.9%	$99K-90.6%	$1.1M	N/A	N/A
Accounts Receivable	N/A	$3K-69.6%	$9K-22.9%	$12K	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$308K+20.7%	$255K-7.5%	$276K-57.8%	$652K-25.9%	$880K-20.1%	$1.1M
Current Liabilities	$300K+17.5%	$255K+9.9%	$232K-51.1%	$474K-46.1%	$880K	N/A
Long-Term Debt	N/A	N/A	N/A	$271K-7.4%	$293K	N/A
Total Equity	$32K-90.5%	$337K-63.8%	$931K-65.6%	$2.7M+3.4%	$2.6M+400.8%	-$870K
Retained Earnings	-$18.3M-19.8%	-$15.3M-7.6%	-$14.2M-14.3%	-$12.4M-19.5%	-$10.4M-58.3%	-$6.6M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$340K-26.8%	$464K-14.3%	$542K-10.4%	$605K+2.2%	$592K-27.0%	$810K-24.0%	$1.1M-8.0%	$1.2M
Current Assets	$265K-28.8%	$373K-14.7%	$437K-16.9%	$526K+6.9%	$492K-17.7%	$598K-25.7%	$805K-4.7%	$844K
Cash & Equivalents	$215K-37.6%	$344K-17.3%	$416K-18.0%	$507K+9.5%	$463K-13.3%	$535K-23.5%	$699K-4.4%	$731K
Inventory	$46K+106.1%	$22K+13.3%	$20K+87.8%	$11K+16.7%	$9K-69.9%	$30K-62.2%	$80K-6.9%	$86K
Accounts Receivable	N/A	N/A	N/A	$3K0.0%	$3K-83.2%	$16K+58.3%	$10K-35.6%	$16K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$308K+43.3%	$215K-46.5%	$402K+13.6%	$354K+38.6%	$255K+44.5%	$176K-64.3%	$494K+2.6%	$481K
Current Liabilities	$300K+48.0%	$202K-47.5%	$385K+9.0%	$354K+38.6%	$255K+44.5%	$176K-64.3%	$494K+5.9%	$467K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$32K-87.1%	$249K+78.1%	$140K-44.3%	$251K-25.4%	$337K-46.9%	$634K+10.7%	$573K-15.6%	$678K
Retained Earnings	-$18.3M-1.9%	-$18.0M-14.8%	-$15.6M-1.9%	-$15.4M-0.6%	-$15.3M-2.2%	-$14.9M-1.9%	-$14.7M-1.6%	-$14.4M

RMSL Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$503K+26.4%	-$683K+13.7%	-$791K+64.6%	-$2.2M-538.3%	-$350K-4.4%	-$335K
Capital Expenditures	N/A	$125K-15.5%	$148K+20.7%	$122K+81.8%	$67K+83.2%	$37K
Free Cash Flow	N/A	-$808K+14.0%	-$939K+60.2%	-$2.4M-464.7%	-$417K-12.2%	-$372K
Investing Cash Flow	N/A	-$125K+15.5%	-$148K-20.7%	-$122K-81.8%	-$67K-83.2%	-$37K
Financing Cash Flow	$254K-54.0%	$552K+400.1%	-$184K-122.6%	$815K-77.9%	$3.7M+905.5%	$367K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$129K-6.1%	-$122K+13.6%	-$141K-28.3%	-$110K	N/A	-$272K-79.3%	-$152K-33.9%	-$113K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$0-100.0%	$50K0.0%	$50K-67.5%	$154K	N/A	$182K+51.7%	$120K-4.0%	$125K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

RMSL Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	24.0%+8.6pp	15.4%+386.9pp	-371.5%-394.0pp	22.5%	N/A	N/A
Operating Margin	N/A	-677.2%+192.5pp	-869.7%-489.9pp	-379.7%	N/A	N/A
Net Margin	N/A	-919.9%-47.2pp	-872.7%-409.2pp	-463.5%	N/A	N/A
Return on Equity	N/A	-320.2%-129.1pp	-191.0%-136.1pp	-54.9%+91.2pp	-146.1%	N/A
Return on Assets	N/A	-182.2%-34.8pp	-147.4%-103.1pp	-44.2%+65.1pp	-109.3%	N/A
Current Ratio	0.89-1.0	1.93-1.7	3.60-2.5	6.14+2.3	3.84	N/A
Debt-to-Equity	9.60+8.8	0.76+0.5	0.30+0.2	0.10-0.0	0.11+1.4	-1.26
FCF Margin	N/A	-689.3%-228.4pp	-460.9%+273.8pp	-734.7%	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	99.6%+12.1pp	87.6%	N/A	N/A	-57.2%-135.6pp	78.5%+1.9pp	76.5%
Operating Margin	N/A	-30631.5%-27883.7pp	-2747.8%	N/A	N/A	-521.0%+554.9pp	-1075.8%-861.2pp	-214.6%
Net Margin	N/A	-31018.9%-25053.4pp	-5965.4%	N/A	N/A	-745.9%+71.7pp	-817.6%-381.2pp	-436.4%
Return on Equity	N/A	-927.3%-721.8pp	-205.5%-171.5pp	-34.0%	N/A	-43.9%-4.5pp	-39.4%-2.2pp	-37.3%
Return on Assets	N/A	-498.2%-445.1pp	-53.1%-39.0pp	-14.1%	N/A	-34.3%-13.2pp	-21.1%+0.6pp	-21.8%
Current Ratio	0.89-1.0	1.84+0.7	1.13-0.4	1.49-0.4	1.93-1.5	3.39+1.8	1.63-0.2	1.81
Debt-to-Equity	9.60+8.7	0.86-2.0	2.87+1.5	1.41+0.6	0.76+0.5	0.28-0.6	0.86+0.2	0.71
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: The current ratio is below 1.0 (0.89), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Stimcell Energetics STME

$6.1M

Bioelectronics Corp BIEL

$4.9M

Adm Tronics ADMT

$5.3M

NUGEN MEDICAL DEVICES INC NGMDF

$3.7M

Kelyniam Global Inc KLYG

$5.5M

Frequently Asked Questions

What is Remsleep Holding's annual revenue?

Remsleep Holding (RMSL) reported $17K in total revenue for fiscal year 2025. This represents a -85.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Remsleep Holding's revenue growing?

Remsleep Holding (RMSL) revenue declined by 85.7% year-over-year, from $117K to $17K in fiscal year 2025.

What is Remsleep Holding's gross margin?

Remsleep Holding (RMSL) had a gross margin of 24.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Remsleep Holding's operating cash flow?

Remsleep Holding (RMSL) generated -$503K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Remsleep Holding's total assets?

Remsleep Holding (RMSL) had $340K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Remsleep Holding have outstanding?

Remsleep Holding (RMSL) had 1.62B shares outstanding as of fiscal year 2025.

What is Remsleep Holding's current ratio?

Remsleep Holding (RMSL) had a current ratio of 0.89 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Remsleep Holding's debt-to-equity ratio?

Remsleep Holding (RMSL) had a debt-to-equity ratio of 9.60 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Remsleep Holding's cash runway?

Based on fiscal year 2025 data, Remsleep Holding (RMSL) had $215K in cash against an annual operating cash burn of $503K. This gives an estimated cash runway of approximately 5 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Remsleep Holding's Piotroski F-Score?

Remsleep Holding (RMSL) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

How financially healthy is Remsleep Holding?

Remsleep Holding (RMSL) scores 2 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.